Physician

James T Finegan, MD

According to 2025 Medicare claims, James Finegan, MD (NPI: 1750332532) practices ophthalmology in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Warren, NJ. This provider's primary affiliated billing organization is FINEGAN EYE ASSOCIATES PA (NPI: 1902856560; TIN: 223176207) and primary practice location at 08865-1632.

Finegan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,081 traditional Medicare patients, billed 5,018 HCPCS/CPT codes, and received $463,872 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 4,685 prescription claims across 852 beneficiaries totaling $635,214 in drug costs, led by Lumigan (Bimatoprost). DME data shows 32 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $688,520 to $463,872. In contrast, Part D prescription costs have risen steadily, from $506,404 to $635,214. For DME billing, this smaller-volume category changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,583	6,284	$688,520
2016	2,653	6,395	$732,035
2017	2,422	5,902	$638,683
2018	2,382	5,928	$662,287
2019	2,206	5,667	$620,673
2020	2,038	5,020	$492,386
2021	1,988	5,126	$550,392
2022	2,112	5,319	$518,971
2023	2,085	5,109	$477,132
2024	2,081	5,018	$463,872

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	728	3,642	$506,404
2016	767	3,712	$534,632
2017	770	3,613	$589,935
2018	761	3,532	$641,699
2019	798	3,604	$690,376
2020	726	3,563	$684,645
2021	838	4,370	$781,698
2022	815	4,403	$833,533
2023	777	4,328	$759,794
2024	852	4,685	$635,214

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	132	136	$10,649
2016	153	157	$11,634
2017	131	132	$9,219
2018	123	123	$9,325
2019	111	113	$8,537
2020	39	39	$2,936
2021	89	89	$6,977
2022	45	45	$3,556
2023	31	31	$2,636
2024	32	32	$2,652

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	1,545	1,565	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	437	643	$74
92083	Exam of visual field with extended testing	418	423	$49
92134	Imaging of retina	515	520	$30
92133	Imaging of optic nerve	422	424	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	331	17,685	$152,751
Restasis	Cyclosporine	144	7,500	$148,622
Alphagan P	Brimonidine Tartrate	181	8,567	$64,422
Cyclosporine	Cyclosporine	81	4,650	$54,171
Rhopressa	Netarsudil Mesylate	96	3,294	$33,662

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	20	20	$2,095
V2020	Frames, purchases	N	12	12	$557

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for James T. Finegan, MD?

Tedicare shows public-source Medicare data for James T. Finegan, MD (NPI 1750332532), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James T. Finegan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James T. Finegan, MD?

James T. Finegan, MD is linked to FINEGAN EYE ASSOCIATES PA (billing NPI 1902856560) in the available physician profile data.

Does James T. Finegan, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.